Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

NCT05462496 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

PROCEDURE: Biopsy
DRUG: FOLFIRINOX
DRUG: Ciprofloxacin
DRUG: Metronidazole
DRUG: Pembrolizumab
PROCEDURE: Surgical Resection

Sponsor

Icahn School of Medicine at Mount Sinai